Published by Coherent Market Insights
Posted on October 6, 2021
3 min readLast updated: January 30, 2026
The nanoemulsion market is set for growth from 2021 to 2028, driven by pharmaceutical applications and innovations in North America.
The Nanoemulsion Market report presents the industry sales and revenue by companies, regions, type and application and forecast to 2028. This report also studies the market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/208
Nanoemulsion helps in protecting drugs from hydrolysis and enzymatic degradation which makes the drug ideal for transport. Moreover, its extreme micro-droplet size of nanoemulsion with the high surface area which makes it efficient as a transportation system is again contributing to the growth of the nanoemulsion market. Also, it does not cause any problem such as flocculation or inherent creaming and coalescence which are usually faced by microemulsions, this property makes it ideal for any form such as sprays, creams, and foams. All these advantages offered are increasing its adoption across the pharmaceutical industry, thereby augmenting the growth of the nanoemulsion market. Additionally, it is also gaining adoption in translational research for targeted cancer therapy which is further stimulating the growth of the market.
In January 2019, NutraFuels, Inc. and Pressure BioSciences, Inc. announced a collaboration on the development of water-soluble, nanoemulsion-based nutraceuticals, and other emulsion-based products, such as cosmetics
In April 2020, – Emerald Health Therapeutics, Inc. has announced its new nanoemulsion-based Fast Action Spray product line, an important step in Emerald’s Cannabis 2.0 strategy and a unique offering in the Canadian cannabis marketplace
In February 2019, Nanogen Labs, Inc. announced its launch as a state-of-the-art nano-emulsion company that develops nanoE
to enhance the water compatibility and bioavailability of cannabinoids
In January 2020, Root Sciences and GEA have announced that they have entered into introduce nano-emulsion technology for use in cannabinoid applications.
North America is expected to dominate the global nanoemulsion market owing to the continuous launch of a new product by key players in the region. For instance, in August 2019, Pressure BioSciences, Inc. announced that they had received two purchase orders for the company’s BaroShear K45 Processing System, a nano emulsification system for CBD-related issues.
Nanoemulsification is a nanoemulsion process that uses emulsive molecules to create a suspension of micron-sized particles in a fluid, such as a water droplet, oil droplets, or even bacteria and other microorganisms. The nano emulsification process is carried out on a dilute suspension of a particular suspension of specific substances in a buffer solution, known as a surfactant. The surfactant must be capable of absorbing the emulsified substances at the lowest rates possible. The main concept behind nanoemulsion is that the emulsification of molecules in a solid suspension is not an easy process to achieve but a highly desirable one.
Top Key Players Include In Nanoemulsion Market: Covaris, Inc, LATITUDE Pharmaceuticals Inc., Taiwan Liposome Company (TLC), Allergan, and Abbott.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/208
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post 2021 to 2028 Nanoemulsion Market Analysis by Type, Application, Growth, Demand, Status and Forecast Report appeared first on Gatorledger.
The article discusses the nanoemulsion market analysis, focusing on growth, applications, and key players from 2021 to 2028.
Nanoemulsions are used in pharmaceuticals to protect drugs from degradation and are gaining traction in cancer therapy.
Key players include Covaris, Inc., LATITUDE Pharmaceuticals Inc., and Abbott.
Explore more articles in the Research Reports category
